+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

ACP Journal Club. Review: statins are not associated with cognitive impairment, Alzheimer disease, or dementia



ACP Journal Club. Review: statins are not associated with cognitive impairment, Alzheimer disease, or dementia



Annals of Internal Medicine 160(10): Jc10-Jc11




(PDF emailed within 0-6 h: $19.90)

Accession: 051291640

Download citation: RISBibTeXText

PMID: 24842432

DOI: 10.7326/0003-4819-160-10-201405200-02010


Related references

ACP Journal Club. Review: statins are not associated with cognitive impairment or dementia in cognitively intact adults. Annals of Internal Medicine 160(10): Jc11, Jc10-Jc11, Jc10, 2014

ACP Journal Club. Review: Statins do not increase adverse cognitive effects in patients with or without initial cognitive impairment. Annals of Internal Medicine 162(10): Jc6-Jc6, 2015

ACP Journal Club. Review: In older persons at vascular risk, statins do not prevent dementia or cognitive decline at 3.5 to 5 years. Annals of Internal Medicine 164(8): Jc42-Jc42, 2016

ACP Journal Club. Review: Cholinesterase inhibitors do not prevent dementia in patients with mild cognitive impairment. Annals of Internal Medicine 160(8): Jc11-Jc11, 2014

ACP Journal Club. Review: cholinesterase inhibitors do not reduce progression to dementia from mild cognitive impairment. Annals of Internal Medicine 158(4): Jc3-Jc3, 2013

ACP Journal Club. Review: Long-term annual conversion rate to dementia was 3.3% in older adults with mild cognitive impairment. Annals of Internal Medicine 150(8): Jc4-J13, 2009

ACP Journal Club. Review: cholinesterase inhibitors but not memantine increase syncope in older adults with mild cognitive impairment or dementia. Annals of Internal Medicine 155(10): Jc5-J10, 2012

Cognitive telerehabilitation in mild cognitive impairment, Alzheimer's disease and frontotemporal dementia: A systematic review. Journal of Telemedicine and Telecare: 1357633x17740390-1357633x17740390, 2017

ACP Journal Club. The Mini-Cog had sensitivity similar to the longer 3MS for detecting cognitive impairment or dementia. Annals of Internal Medicine 157(8): Jc4-Jc8, 2012

Metformin and Alzheimer's disease, dementia and cognitive impairment: a systematic review protocol. Jbi Database of Systematic Reviews and Implementation Reports 15(8): 2055-2059, 2017

Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort. Journal of Alzheimer's Disease 51(4): 1111-1118, 2016

Frequency of Depressive Syndromes in Elderly Individuals with No Cognitive Impairment, Mild Cognitive Impairment, and Alzheimer's Disease Dementia in a Memory Clinic Setting. Dementia and Geriatric Cognitive Disorders 42(3-4): 135-145, 2016

Differential Impairment of Cognitive and Affective Mentalizing Abilities in Neurodegenerative Dementias: Evidence from Behavioral Variant of Frontotemporal Dementia, Alzheimer's Disease, and Mild Cognitive Impairment. Journal of Alzheimer's Disease 50(4): 1011-1022, 2016

Semi-quantitative analysis of perfusion of Brodmann areas in the differential diagnosis of cognitive impairment in Alzheimer's disease, fronto-temporal dementia and mild cognitive impairment. Hellenic Journal of Nuclear Medicine 12(2): 110-114, 2009

18F-FDG PET for Prediction of Conversion to Alzheimer's Disease Dementia in People with Mild Cognitive Impairment: An Updated Systematic Review of Test Accuracy. Journal of Alzheimer's Disease, 2018